Review
doi: 10.1016/j.cger.2010.02.010.
Benign prostatic hyperplasia
Affiliations
- PMID: 20497842
- DOI: 10.1016/j.cger.2010.02.010
Item in Clipboard
Review
Benign prostatic hyperplasia
Clin Geriatr Med.
2010 May.
Abstract
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies. The management includes medical and surgical options. Medical options include alpha-1-adrenergic receptor blockers, 5alpha-reductase inhibitors, and combinations of these and other medications. Surgical options include endoscopic procedures, open procedures, and laser procedures.
Copyright 2010. Published by Elsevier Inc.
Similar articles
-
Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.Clin Ther. 2006 Jan;28(1):13-25. doi: 10.1016/j.clinthera.2006.01.004. Clin Ther. 2006. PMID: 16490576 Review.
-
The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?J Urol. 1996 Jun;155(6):1971-4. J Urol. 1996. PMID: 8618299
-
Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study.Eur Urol. 2013 Sep;64(3):493-501. doi: 10.1016/j.eururo.2013.02.026. Epub 2013 Feb 26. Eur Urol. 2013. PMID: 23465519
-
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.Eur Urol. 2011 Oct;60(4):809-25. doi: 10.1016/j.eururo.2011.06.037. Epub 2011 Jun 29. Eur Urol. 2011. PMID: 21726934 Review.
-
Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options.Aging Male. 2011 Sep;14(3):141-9. doi: 10.3109/13685538.2010.548881. Epub 2011 Jan 19. Aging Male. 2011. PMID: 21247241 Review.
Cited by
-
Radiology of fibrosis part III: genitourinary system.J Transl Med. 2024 Jul 3;22(1):616. doi: 10.1186/s12967-024-05333-1. J Transl Med. 2024. PMID: 38961396 Free PMC article. Review.
-
Panax ginseng C.A. meyer alleviates benign prostatic hyperplasia while preventing finasteride-induced side effects.Front Pharmacol. 2023 Jan 12;14:1039622. doi: 10.3389/fphar.2023.1039622. eCollection 2023. Front Pharmacol. 2023. PMID: 36713838 Free PMC article.
-
Effect of Beclin-1 gene silencing on autophagy and apoptosis of the prostatic hyperplasia epithelial cells.Clinics (Sao Paulo). 2022 Sep 8;77:100076. doi: 10.1016/j.clinsp.2022.100076. eCollection 2022. Clinics (Sao Paulo). 2022. PMID: 36088885 Free PMC article.
-
Protective Role of 4-(4-Hydroxy-3-methoxyphenyl)-2-Butanone on Prostatic Cells Hyperplasia of Rats and Human, 5α-reductase Inhibition Pathway.J Microsc Ultrastruct. 2021 May 24;9(4):164-169. doi: 10.4103/JMAU.JMAU_37_20. eCollection 2021 Oct-Dec. J Microsc Ultrastruct. 2021. PMID: 35070691 Free PMC article.
-
Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.Inflammopharmacology. 2020 Oct;28(5):1407-1420. doi: 10.1007/s10787-020-00743-1. Epub 2020 Aug 12. Inflammopharmacology. 2020. PMID: 32785828
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
